Surgery and adjuvant chemotherapy use among veterans with colon cancer: Insights from a California study

Journal of Clinical Oncology

Volumn 28, Issue 15, 2010, Pages 2571-2576

  Hynes, Denise M ^a   Tarlov, Elizabeth ^a   Durazo Arvizu, Ramon ^a   Perrin, Ruth ^a   Zhang, Qiuying ^a   Weichle, Thomas ^a   Ferreira, M Rosario ^a   Lee, Todd ^a   Benson, Al B ^a   Bhoopalam, Nirmala ^a   Bennett, Charles L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; COLON CANCER; CONFIDENCE INTERVAL; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; UNITED STATES; VETERAN; COLON TUMOR; ECONOMICS; GOVERNMENT; HEALTH CARE QUALITY; PUBLIC HOSPITAL; STANDARD;

AGED; AGED, 80 AND OVER; CALIFORNIA; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 77956396031     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.5200     Document Type: Article

References (30)

1. American Cancer Society: Cancer Facts & Figures 2008. Atlanta, GA, American Cancer Society, 2008
2. Jessup JM, Stewart AK, Greene FL, et al: Adjuvant chemotherapy for stage III colon cancer: Implications of ethnicity, age and differentiation. JAMA 294:2703-2711, 2005 (Pubitemid 41770099)
3. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al: Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21:1293-1300, 2003 (Pubitemid 46606406)
4. US Department of Veterans Affairs: VHA DIRECTIVE 2003-034: National Cancer Strategy. http://www1.va.gov/cancer/docs/NationalCancerDirective.doc
5. Hynes DM, Koelling K, Stroupe K, et al: Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care 45:214-223, 2007
6. Borowsky SJ, Cowper DC: Dual use of VA and non-VA primary care. J Gen Intern Med 14:274-280, 1999 (Pubitemid 29226672)
7. Sundararajan V, Grann VR, Jacobson JS, et al: Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: A population-based study. Cancer J 7:213-218, 2001
8. Schrag D, Cramer LD, Bach PB, et al: Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 93:850-857, 2001 (Pubitemid 32590779)
9. Craig TJ, Petzel R: Management perspectives on research contributions to practice through collaboration in the U.S. veterans Health Administration: QUERI Series. Implement Sci 4:8, 2009
10. Chao HH, Schwartz AR, Hersch J, et al: Improving colorectal cancer screening and care in the Veterans Affairs healthcare system. Clin Colorectal Cancer 8:22-28, 2009
11. Hynes DM, Cowper D, Manheim L, et al: Research findings from the VA Medicare Data Merge Initiative: Veterans' enrollment, access and use of Medicare and VA healthcare: Report to the Undersecretary of Health Department of Veterans Affairs. Hines, IL, VA Information Resource Center, US Dept of Veterans Affairs, 2003. http://www.virec.research.va.gov/DataSourcesName/VA-CMS/ Medicare/USHreport.pdf
12. Murphy PA, Cowper DC, Seppala G, et al: Veterans Health Administration inpatient and outpatient care data: an overview. Eff Clin Pract 5:E4, 2002 (suppl 3)
13. Thoburn KK, German RR, Lewis M, et al: Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer 109:1607-1616, 2007 (Pubitemid 46595697)
14. Clegg LX, Reichman ME, Hankey BF, et al: Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: Implications for health disparity studies Cancer Causes Control 18:177-187, 2007
15. Cress R, Zaslavsky A, West DW, et al: Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care 41:1006-1012, 2007
16. American Joint Committee on Cancer: Manual for Staging of Cancer (ed 5). Philadelphia, PA, J. B. Lippincott, 1997
17. Charlson M, Szatrowski TP, Peterson J, et al: Validation of a combined comorbidity index. J Clin Epidemiol 47:1245-1251, 1994 (Pubitemid 24361532)
18. Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 46:1075-1079, 1993
19. Deyo RA, Cherkin DC, Ciol MA, et al: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
20. Klabunde CN, Harlan LC, Warren JL: Data sources for measuring comorbidity: A comparison of hospital records and Medicare claims for cancer patients. Med Care 44:921-928, 2006 (Pubitemid 44454569)
21. Klabunde CN, Potosky A, Legler J, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:258-1267, 2000
22. StataCorp: Stata Statistical Software: Release 10. College Station, TX, StataCorp LP, 2007
23. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56:106-130, 2006
24. Dominitz JA, Samsa GP, Landsman P, et al: Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer 82:2312-2320, 1998 (Pubitemid 28283436)
25. Rabeneck L, Souchek J, El-Serag HB: Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol 98:1186-1192, 2003 (Pubitemid 36733786)
26. Abraham NS, Gossey JT, Davila JA, et al: Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol 101:1320-1328, 2006 (Pubitemid 43830000)
27. Moertel CG, Fleming TR, Macdonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990 (Pubitemid 20042739)
28. NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450, 1990
29. Arkenau HT, Bermann A, Rettig K, et al: 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: Long-term follow-up results of the adjCCA-01 trial. Ann Oncol 14:395-399, 2003 (Pubitemid 36367416)
30. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345:939-944, 1995